MARKET WIRE NEWS
  1. Home
  2. Stock
  3. BDRX
  4. News
BDRX
Quote
Short
News
Articles
Message Board

Biodexa Pharmaceuticals plc (NASDAQ : BDRX ) News

Biodexa Pharmaceuticals plc (NASDAQ: BDRX) News Releases

BDRX News Releases
BDRX : NASDAQ
SeekingAlpha
Biodexa Pharmaceuticals GAAP EPS of £0.00
BDRX : NASDAQ
SeekingAlpha
Biodexa Pharmaceuticals GAAP EPS of -£0.0002
BDRX : NASDAQ
GlobeNewswire
Interim results for the six months ended June 30, 2025
BDRX : NASDAQ
ACCESS Newswire
Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled
BDRX : NASDAQ
GlobeNewswire
ADR Ratio Change Effective
BDRX : NASDAQ
ACCESS Newswire
How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable Market
BDRX : NASDAQ
SeekingAlpha
Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance
BDRX : NASDAQ
GlobeNewswire
ADR Ratio Change
BDRX : NASDAQ
GlobeNewswire
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
BDRX : NASDAQ
US Earnings Reports
Expected US Company Earnings on Friday, July 11th, 2025
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.